<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36806936</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-699X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The clinical respiratory journal</Title><ISOAbbreviation>Clin Respir J</ISOAbbreviation></Journal><ArticleTitle>Clinical features of asthma with connective tissue diseases.</ArticleTitle><Pagination><StartPage>303</StartPage><EndPage>310</EndPage><MedlinePgn>303-310</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/crj.13595</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The clinical features of asthma with connective tissue diseases (CTDs) are not well-known. This study therefore aimed to investigate the clinical characteristics of asthma with CTDs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively examined the records of adults (&#x2265;18&#x2009;years old) with asthma followed up between January 2010 and December 2019. We then compared the clinical features of asthma with and without CTDs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 568 subjects with asthma, 42 subjects (7.4%) had CTDs. The most frequent concomitant CTD was rheumatoid arthritis (n&#x2009;=&#x2009;23, 54.8%), followed by systemic lupus erythematosus (n&#x2009;=&#x2009;6, 14.3%). The proportion of women (with vs. without CTDs, 85.7% vs. 56.5%, p&#x2009;&lt;&#x2009;0.001) and Global Initiative for Asthma step were higher (Step 4 or 5, with vs. without CTDs, 81.0% vs. 62.0%, p&#x2009;=&#x2009;0.01) in asthma with CTDs, whereas frequency of allergic rhinitis was higher in asthma without CTDs (with vs. without CTDs, 7.1% vs. 26.1%, p&#x2009;=&#x2009;0.005). Eosinophil ratio (with vs. without CTDs, 2.1% vs. 3.5%, p&#x2009;=&#x2009;0.009) and total immunoglobulin E level (with vs. without CTDs, 43&#x2009;IU/mL vs. 237&#x2009;IU/mL, p&#x2009;=&#x2009;0.002) were lower in asthma with CTDs. In terms of lung function, percentage predicted forced vital capacity (with vs. without CTDs, 86.7% vs. 99.7%, p&#x2009;=&#x2009;0.008) and percentage predicted forced expiratory volume in 1&#xa0;s (%FEV1) (with vs. without CTDs, 77.2% vs. 88.4%, p&#x2009;=&#x2009;0.02) were all lower in asthma with CTDs. With multivariable analysis, CTDs (odds ratio [OR] 2.8, 95%CI 1.3-6.0; p&#x2009;=&#x2009;0.008), chronic obstructive pulmonary disease (OR 3.8, 95%CI 2.1-6.7; p&#x2009;&lt;&#x2009;0.001) and asthma onset at &lt;20&#x2009;years old (OR 1.8, 95%CI 1.1-3.2; p&#x2009;=&#x2009;0.03) were associated with low FEV1 (defined as %FEV1 &lt;&#x2009;80%) in asthma.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Asthma with CTDs was related to lower lung function and low-T2 inflammation asthma.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. The Clinical Respiratory Journal published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Keisuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horita</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hara</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Nobuaki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaneko</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Teijin Pharma</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Respir J</MedlineTA><NlmUniqueID>101315570</NlmUniqueID><ISSNLinking>1752-6981</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003240" MajorTopicYN="Y">Connective Tissue Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T2-low asthma</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">connective tissue diseases</Keyword><Keyword MajorTopicYN="N">lung function</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword></KeywordList><CoiStatement>K.W. has received research grants and/or personal fees from AstraZeneca, Novartis, Ono Pharmaceutical, Boehringer Ingelheim and Daiichi Sankyo outside of the present work. N.H. has received research grants and/or personal fees from Taiho Pharmaceutical outside of the present work. Y.H. has received research grants and/or personal fees from AstraZeneca, GlaxoSmithKline and Boehringer Ingelheim outside of the present work. N.K. has received research grants and/or personal fees from Chugai Pharmaceutical, AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Pfizer, Sanofi, Ono Pharmaceutical, MSD, Bristol Myers Squibb, Eli Lilly, Daiichi Sankyo and Kyowa Kirin outside of the present work. T.K. has received research grants and/or personal fees from Chugai Pharmaceutical, AstraZeneca, Novartis, GlaxoSmithKline, Boehringer Ingelheim, KYORIN Pharmaceutical, Otsuka Pharmaceutical, Eli Lilly, Taiho Pharmaceutical, Sanofi, Pfizer, Shionogi and Teijin Pharma outside of the present work.&#xa0;This study was partially supported by research grants from Teijin Pharma. Teijin Pharma had no role in this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>11</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36806936</ArticleId><ArticleId IdType="pmc">PMC10113276</ArticleId><ArticleId IdType="doi">10.1111/crj.13595</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783&#x2010;800. doi:10.1016/S0140-6736(17)33311-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)33311-1</ArticleId><ArticleId IdType="pubmed">29273246</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulet LP, Boulay M&#xc8;. Asthma&#x2010;related comorbidities. Expert rev. Respir Med. 2011;5(3):377&#x2010;393. doi:10.1586/ers.11.34</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/ers.11.34</ArticleId><ArticleId IdType="pubmed">21702660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford DK, Lockey RF. Asthma and comorbidities. Curr Opin Allergy Clin Immunol. 2013;13(1):78&#x2010;86. doi:10.1097/ACI.0b013e32835c16b6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACI.0b013e32835c16b6</ArticleId><ArticleId IdType="pubmed">23222157</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne S, Mannino D, Sin DD. Asthma&#x2010;COPD overlap and chronic airflow obstruction: definitions, management, and unanswered questions. J Allergy Clin Immunol Pract. 2020;8(2):483&#x2010;495. doi:10.1016/j.jaip.2019.10.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2019.10.044</ArticleId><ArticleId IdType="pubmed">31740296</ArticleId></ArticleIdList></Reference><Reference><Citation>Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73(5):993&#x2010;1002. doi:10.1111/all.13373</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13373</ArticleId><ArticleId IdType="pubmed">29197105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccardelli A, Liu X, Ford JA, et al. Asthma and elevation of anti&#x2010;citrullinated protein antibodies prior to the onset of rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):246. doi:10.1186/s13075-019-2035-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-2035-3</ArticleId><ArticleId IdType="pmc">PMC6868779</ArticleId><ArticleId IdType="pubmed">31753003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Min C, Oh DJ, Choi HG. Increased risk of asthma in patients with rheumatoid arthritis: a longitudinal follow&#x2010;up study using a national sample cohort. Sci Rep. 2019;9(1):6957. doi:10.1038/s41598-019-43481-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-43481-3</ArticleId><ArticleId IdType="pmc">PMC6502877</ArticleId><ArticleId IdType="pubmed">31061451</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N, Ponvilawan B, Wongtrakul W, Ungprasert P. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta&#x2010;analysis. Clin Rheumatol. 2021;40(2):529&#x2010;536. doi:10.1007/s10067-020-05279-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05279-x</ArticleId><ArticleId IdType="pubmed">32638252</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna MT, Subramanian A, Adderley NJ, et al. Allergic diseases and long&#x2010;term risk of autoimmune disorders: longitudinal cohort study and cluster analysis. Eur Respir J. 2019;54(5):1900476. doi:10.1183/13993003.00476-2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00476-2019</ArticleId><ArticleId IdType="pubmed">31413164</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheen YH, Rolfes MC, Wi CI, et al. Association of asthma with rheumatoid arthritis: a population&#x2010;based case&#x2010;control study. J Allergy Clin Immunol Pract. 2018;6(1):219&#x2010;226. doi:10.1016/j.jaip.2017.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2017.06.022</ArticleId><ArticleId IdType="pmc">PMC5760301</ArticleId><ArticleId IdType="pubmed">28803184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford JA, Liu X, Chu SH, et al. Asthma, chronic obstructive pulmonary disease, and subsequent risk for incident rheumatoid arthritis among women: a prospective cohort study. Arthritis. Rheumatology. 2020;72(5):704&#x2010;713. doi:10.1002/art.41194</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41194</ArticleId><ArticleId IdType="pmc">PMC7188599</ArticleId><ArticleId IdType="pubmed">32129572</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Fan X, Jiang C, Arevalo Molina AB, Salgado M, Xu J. Rheumatoid arthritis is associated with increased in&#x2010;hospital mortality in asthma exacerbations: a nationwide study. Clin Rheumatol. 2018;37(7):1971&#x2010;1976. doi:10.1007/s10067-018-4114-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4114-2</ArticleId><ArticleId IdType="pubmed">29671191</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung C, Sin DD. Asthma&#x2010;COPD overlap: what are the important questions? Chest. 2022;161(2):330&#x2010;344. doi:10.1016/j.chest.2021.09.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.09.036</ArticleId><ArticleId IdType="pubmed">34626594</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida A, Sakaue K, Inoue H. Epidemiology of asthma&#x2010;chronic obstructive pulmonary disease overlap (ACO). Allergol Int. 2018;67(2):165&#x2010;171. doi:10.1016/j.alit.2018.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2018.02.002</ArticleId><ArticleId IdType="pubmed">29551279</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton E, Price DB, Tran TN, et al. Cluster analysis of inflammatory biomarker expression in the international severe asthma registry. J Allergy Clin Immunol Pract. 2021;9(7):2680&#x2010;2688. doi:10.1016/j.jaip.2021.02.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.02.059</ArticleId><ArticleId IdType="pubmed">33744476</ArticleId></ArticleIdList></Reference><Reference><Citation>Jee AS, Sheehy R, Hopkins P, et al. Diagnosis and management of connective tissue disease&#x2010;associated interstitial lung disease in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2021;26(1):23&#x2010;51. doi:10.1111/resp.13977</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.13977</ArticleId><ArticleId IdType="pmc">PMC7894187</ArticleId><ArticleId IdType="pubmed">33233015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka A, Uno T, Sato H, et al. Predicting future risk of exacerbations in Japanese patients with adult asthma: a prospective 1&#x2010;year follow up study. Allergol Int. 2017;66(4):568&#x2010;573. doi:10.1016/j.alit.2017.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2017.02.013</ArticleId><ArticleId IdType="pubmed">28318883</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly CK, Mamun M, Alcock SM, Prescott RJ. The Darlington and Northallerton prospective asthma study: best function predicts mortality during the first 10 years. Respir Med. 1998;92(11):1274&#x2010;1280. doi:10.1016/S0954-6111(98)90228-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0954-6111(98)90228-1</ArticleId><ArticleId IdType="pubmed">9926140</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito AJ, Chu SG, Madan R, Doyle TJ, Dellaripa PF. Thoracic manifestations of rheumatoid arthritis. Clin Chest Med. 2019;40(3):545&#x2010;560. doi:10.1016/j.ccm.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6994971</ArticleId><ArticleId IdType="pubmed">31376890</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilsher M, Voight L, Milne D, et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med. 2012;106(10):1441&#x2010;1446. doi:10.1016/j.rmed.2012.06.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2012.06.020</ArticleId><ArticleId IdType="pubmed">22795504</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Vasquez MM, Halonen M, Martinez FD, Guerra S. Asthma, airflow limitation and mortality risk in the general population. Eur Respir J. 2015;45(2):338&#x2010;346. doi:10.1183/09031936.00108514</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00108514</ArticleId><ArticleId IdType="pmc">PMC4683019</ArticleId><ArticleId IdType="pubmed">25323227</ArticleId></ArticleIdList></Reference><Reference><Citation>Okayama Y, Kawayama T, Kinoshita T, et al. Impact of airflow obstruction on long&#x2010;term mortality in patients with asthma in Japan. Allergol Int. 2019;68(4):462&#x2010;469. doi:10.1016/j.alit.2019.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2019.04.009</ArticleId><ArticleId IdType="pubmed">31160195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Anzaghe M, Sch&#xfc;lke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cell. 2020;9(4):880. doi:10.3390/cells9040880</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040880</ArticleId><ArticleId IdType="pmc">PMC7226834</ArticleId><ArticleId IdType="pubmed">32260219</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafael&#x2010;Vidal C, P&#xe9;rez N, Altab&#xe1;s I, Garcia S, Pego&#x2010;Reigosa JM. Blocking IL&#x2010;17: a promising strategy in the treatment of systemic rheumatic diseases. Int J Mol Sci. 2020;21(19):7100. doi:10.3390/ijms21197100</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197100</ArticleId><ArticleId IdType="pmc">PMC7582977</ArticleId><ArticleId IdType="pubmed">32993066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze E, Bhalla A, Nair P. Mechanisms and therapeutic strategies for non&#x2010;T2 asthma. Allergy. 2020;75(2):311&#x2010;325. doi:10.1111/all.13985</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13985</ArticleId><ArticleId IdType="pubmed">31309578</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T. Use of systemic corticosteroids for reasons other than asthma in subjects with asthma. Respiration. 2022;101(2):109&#x2010;115. doi:10.1159/000518461</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518461</ArticleId><ArticleId IdType="pmc">PMC8985010</ArticleId><ArticleId IdType="pubmed">34515214</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo JR, Peters SP, Busse WW. Asthma exacerbations: pathogenesis, prevention, and treatment. J Allergy Clin Immunol Pract. 2017;5(4):918&#x2010;927. doi:10.1016/j.jaip.2017.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2017.05.001</ArticleId><ArticleId IdType="pmc">PMC5950727</ArticleId><ArticleId IdType="pubmed">28689842</ArticleId></ArticleIdList></Reference><Reference><Citation>Almirall J, Serra&#x2010;Prat M, Bol&#xed;bar I, Balasso V. Risk factors for community&#x2010;acquired pneumonia in adults: a systematic review of observational studies. Respiration. 2017;94(3):299&#x2010;311. doi:10.1159/000479089</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000479089</ArticleId><ArticleId IdType="pubmed">28738364</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Asai Y, Tsurikisawa N, Oshikata C, Kaneko T. Factors associated with pneumococcal vaccine uptake in elderly subjects referred to the respiratory department. Nagoya J Med Sci. 2020;82(3):469&#x2010;476. doi:10.18999/nagjms.82.3.469</Citation><ArticleIdList><ArticleId IdType="doi">10.18999/nagjms.82.3.469</ArticleId><ArticleId IdType="pmc">PMC7548246</ArticleId><ArticleId IdType="pubmed">33132431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A, Plentz A, Sieroslawski A, et al. Use of pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany. Respir Med. 2020;174:106207. doi:10.1016/j.rmed.2020.106207</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106207</ArticleId><ArticleId IdType="pubmed">33152552</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimi C, Ferri S, Campisi R, Crimi N. The link between asthma and bronchiectasis: state of the art. Respiration. 2020;99(6):463&#x2010;476. doi:10.1159/000507228</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507228</ArticleId><ArticleId IdType="pubmed">32464625</ArticleId></ArticleIdList></Reference><Reference><Citation>Holers VM, Demoruelle MK, Kuhn KA, et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol. 2018;14(9):542&#x2010;557. doi:10.1038/s41584-018-0070-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0070-0</ArticleId><ArticleId IdType="pmc">PMC6704378</ArticleId><ArticleId IdType="pubmed">30111803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Lee EB, Shin ES, et al. The interaction between allelic variants of CD86 and CD40LG: a common risk factor of allergic asthma and rheumatoid arthritis. Allergy Asthma Immunol Res. 2014;6(2):137&#x2010;141. doi:10.4168/aair.2014.6.2.137</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2014.6.2.137</ArticleId><ArticleId IdType="pmc">PMC3936042</ArticleId><ArticleId IdType="pubmed">24587950</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez&#x2010;Morales S, Vel&#xe1;zquez&#x2010;Cruz R, Ram&#xed;rez&#x2010;Bello J, et al. Tumor necrosis factor&#x2010;alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol. 2009;70(4):251&#x2010;256. doi:10.1016/j.humimm.2009.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2009.01.027</ArticleId><ArticleId IdType="pubmed">19480843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Al Heialy S, Hamid Q. Role of IL&#x2010;17 in asthma pathogenesis and its implications for the clinic. Expert Rev Respir Med. 2019;13(11):1057&#x2010;1068. doi:10.1080/17476348.2019.1666002</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2019.1666002</ArticleId><ArticleId IdType="pubmed">31498708</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023&#x2010;2038. doi:10.1016/S0140-6736(16)30173-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)30173-8</ArticleId><ArticleId IdType="pubmed">27156434</ArticleId></ArticleIdList></Reference><Reference><Citation>von Mutius E, Smits HH. Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention. Lancet. 2020;396(10254):854&#x2010;866. doi:10.1016/S0140-6736(20)31861-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31861-4</ArticleId><ArticleId IdType="pubmed">32910907</ArticleId></ArticleIdList></Reference><Reference><Citation>Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract. 2014;2(6):645&#x2010;648. doi:10.1016/j.jaip.2014.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2014.09.004</ArticleId><ArticleId IdType="pubmed">25439351</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>